The 13th APRL Asia Pharmaceutical R&D Leadership Summit Guest List Collection

"The 13th APRL Asia Pharmaceutical R&D Leadership Summit 2025", which is organized by Shine Consultant , supported by SUBIA and YAFO?Capital will be held on February 26-27, 2025?in Shanghai with the theme of “Crossing Cycle,Integrating Innovation,Empowering Clinical”.

?

Based on the success of the previous twelve sessions, this conference will once again bring together 70+ pharmaceutical R&D leaders and 1500+ industry colleagues?to gather in Shanghai to explore differentiated R&D strategies, empower preclinical research and clinical development, improve clinical development efficiency, innovate collaborative development models, and enable innovation to truly empower the clinic!

?

Speakers

Xingli WANG, Executive President, CEO of Global R&D Center, Shanghai Fosun Pharmaceutical（Group）Co.Ltd.

Jianxin YANG(Jason), CEO & President of R&D, Executive Director, CStone Pharmaceuticals

Kangsheng HUANG, COO, RemeGen Ltd.

Dongzhou LIU(Jeffery), Chief Scientific Officer/ Prisident of Global Research and Development Center, Huadong Medicine Co., Ltd.

Bo CHEN, CSO, China Resources Pharmaceutical Group Limited

Mingxiu HU, SVP, Akeso Biopharma Inc.

Shuizhong YAN(James), COO, Global R&D，Zai Lab (Shanghai) Co., Ltd.

Hao LIU, Deputy General Manager, Translational Medicine, Shanghai Research Institute, Qilu Pharmaceuticals

Zhenping WU, Executive Vice President, HUTCHMED

Aimin HUI, Founder, Chairman and CEO,EncureGen Pharma

Yan SHI(Rachel), CMO, GeneQuantum Healthcare

Jianjun JIN(James), CMO, Argo Biopharma

Robert J. Lee, Chief Scientific Officer, Zhejiang Haichang ?Biotech., LTD.

Jingjun QIU(Jeannie), FosunPharma Partner, Global R&D VP, FosunPharma

Bingke YU, Head of External Innovation Hub,China, Boehringer-Ingelheim

Fei CAO(Francis), Co-founder & COO, InxMed (Nanjing) Co., Ltd.

Longcheng LI, CEO, Ractigenk Therapeutics

Qingmei SHI, CMO, CStone Pharmaceuticals

Amin LI, VP, Medicinal Chemistry, Jacobio Pharmaceuticals Co.,Ltd.

Yuhong ZHOU, CSO, Bliss Biopharmaceutical (Hangzhou) Co., Ltd.

Xuebin LIU(Leo), CSO, InxMed

Yuli DING, SVP,Clinical Development, Jacobio Pharmaceuticals Co., Ltd

Xinghai LI, CTO, Hinova Pharmaceuticals Inc.

Yu WANG, CMO, GENFLEET THERAPEUTICS

Wenxin XU, Vice-president/Head of immunology, Viromab Bioscience/Betta Pharmaceuticals

Jinyu HUANG, Senior Vice President of Chemistry, Co-Founder, Rona Therapeutics

Kevin WANG，CTO，Bivision Pharmaceuticals, Inc.

Bo SHAN，CEO，BoomRay Pharmaceuticals Co., Ltd.

Haige SHEN，SVP of clinical development，Genfleet Therapeutics

Hanying BAO，Senior Vice President, Clinical Management，yl-pharma

Zihao WANG，Chief Executive Officer，Immorna

Xiaoming WU，CEO，Yantai Lannacheng Biotechnology Co.,Ltd.

Maijing LIAO，CEO，AlphaGen Therapeutics

Renbin ZHAO，Vice President of Clinical Development and Medical Research，InnoCare Pharma

……Continuously updating

?

Organizer

Shine Consultant International

Supporter

SUBIA

SUBIA (Sino-US Biomedical Investment Association) and SUBIA Forum is a biomedical professional organization, established in 2014 in China and the United States. ?SUBIA has been playing active role in linking the Chinese and US biopharmaceutical industries for promoting drug innovation and biotech investment. Over the years, SUBIA has had many collaborations and resources in dealing with international multinational companies. With the progress of China's biotech continued growth, SUBIA will play a more important role in promoting overseas licensing and technical transfer in BD international business cooperation by bridging US and China as well as rest of the world.

YAFO Capital

Founded in 2013, YAFO Capital is a Shanghai based boutique investment and advisory firm, with professional team in our China, U.S., EU and SEA offices. Partnering with Pharmaceutical companies, YAFO Fund mainly invests in global assets. YAFO Life Sciences is a leading advisory boutique focused on asset transactions. YAFO has built a strong proven track record and closed dozens of in-licensing and out-licensing transactions with global pharma and biotech companies. Over the past five years, YAFO has been ranked as the No. 1 advisor for China cross border licensing transactions. ?For more information, please visit www.yafocapital.com

?

Various forms of cooperation

Keynote speeches, exhibition display, one-on-one appointment system，social dinner party, lunch tea break, information kits, cocktail parties, roll-up banner?and other forms of collaboration will help you showcase your company's latest products/technologies in all aspects! Through face-to-face interaction, you will be able to find new partners, discover new R&D ideas and obtain more quality resources.

?

【For More Information, please contact us】

Sunny Sun

T: 021 6095 0241

E-mail: [email protected]